Cleared Traditional

K140829 - UNICEL DXC SYNCHRON SYSTEMS HEMOGLOBIN A1C3 (HBA1C3) REAGENT (FDA 510(k) Clearance)

Jul 2014
Decision
104d
Days
Class 2
Risk

K140829 is an FDA 510(k) clearance for the UNICEL DXC SYNCHRON SYSTEMS HEMOGLOBIN A1C3 (HBA1C3) REAGENT. This device is classified as a Assay, Glycosylated Hemoglobin (Class II - Special Controls, product code LCP).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on July 14, 2014, 104 days after receiving the submission on April 1, 2014.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 864.7470.

Submission Details

510(k) Number K140829 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2014
Decision Date July 14, 2014
Days to Decision 104 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LCP — Assay, Glycosylated Hemoglobin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7470